Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIGA: Intracameral Mydriatics vs Drops vs Insert in POAG Cataract Surgery
NCT05925894Completed
- Sponsor
- Policlinico Gemelli
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of Mydrane in cataract (3 arms), sponsored by Policlinico Gemelli. Primary endpoints: Stability of mydriasis at 1 hour and Duration of surgery at 1 hour. Started Mar 2021; status: completed.
02
Drugs
Mydrane
03
Conditions
cataract
Beyond the preview
Go deeper on NCT05925894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05925894.